Mylan finally crosses the finish line with long-awaited generic of GlaxoSmithKline's Advair

As Leerink Partners analyst Ami Fadia put it in a note to clients Wednesday afternoon, Godot is finally here. And that Godot is generic Advair. After a slew of rejections  and delays, the FDA approved the first copycat to the GlaxoSmithKline respiratory blockbuster.